342 related articles for article (PubMed ID: 15369590)
1. Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro.
Medveczky MM; Sherwood TA; Klein TW; Friedman H; Medveczky PG
BMC Med; 2004 Sep; 2():34. PubMed ID: 15369590
[TBL] [Abstract][Full Text] [Related]
2. Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.
Huang L; Yang M; Yuan Y; Li X; Kuang E
Antiviral Res; 2017 Feb; 138():68-78. PubMed ID: 27939840
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
Zhang X; Wang JF; Kunos G; Groopman JE
Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation.
Yang M; Huang L; Li X; Kuang E
Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.
Xu D; Coleman T; Zhang J; Fagot A; Kotalik C; Zhao L; Trivedi P; Jones C; Zhang L
J Virol; 2007 Jun; 81(11):6068-78. PubMed ID: 17376914
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells.
Chen YJ; Tsai WH; Chen YL; Ko YC; Chou SP; Chen JY; Lin SF
PLoS One; 2011 Mar; 6(3):e17809. PubMed ID: 21423768
[TBL] [Abstract][Full Text] [Related]
8. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
9. Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.
Lu M; Suen J; Frias C; Pfeiffer R; Tsai MH; Chuang E; Zeichner SL
J Virol; 2004 Dec; 78(24):13637-52. PubMed ID: 15564474
[TBL] [Abstract][Full Text] [Related]
10. Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4.
Qin D; Zeng Y; Qian C; Huang Z; Lv Z; Cheng L; Yao S; Tang Q; Chen X; Lu C
Cell Microbiol; 2008 Mar; 10(3):713-28. PubMed ID: 18042256
[TBL] [Abstract][Full Text] [Related]
11. 25-Hydroxycholesterol Inhibits Kaposi's Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses.
Serquiña AKP; Tagawa T; Oh D; Mahesh G; Ziegelbauer JM
mBio; 2021 Dec; 12(6):e0290721. PubMed ID: 34781692
[TBL] [Abstract][Full Text] [Related]
12. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
13. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
14. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
Cirone M
Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
[TBL] [Abstract][Full Text] [Related]
15. Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.
Gorres KL; Daigle D; Mohanram S; Miller G
J Virol; 2014 Jul; 88(14):8028-44. PubMed ID: 24807711
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapy.
Andrei G; Snoeck R
Curr Opin Infect Dis; 2015 Dec; 28(6):611-24. PubMed ID: 26524334
[TBL] [Abstract][Full Text] [Related]
17. Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML.
Wu FY; Ahn JH; Alcendor DJ; Jang WJ; Xiao J; Hayward SD; Hayward GS
J Virol; 2001 Feb; 75(3):1487-506. PubMed ID: 11152521
[TBL] [Abstract][Full Text] [Related]
18. Function of Rta is essential for lytic replication of murine gammaherpesvirus 68.
Wu TT; Tong L; Rickabaugh T; Speck S; Sun R
J Virol; 2001 Oct; 75(19):9262-73. PubMed ID: 11533188
[TBL] [Abstract][Full Text] [Related]
19. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.
Vieira J; O'Hearn P; Kimball L; Chandran B; Corey L
J Virol; 2001 Feb; 75(3):1378-86. PubMed ID: 11152511
[TBL] [Abstract][Full Text] [Related]
20. Tumor Microenvironment Conditioning by Abortive Lytic Replication of Oncogenic γ-Herpesviruses.
Münz C
Adv Exp Med Biol; 2020; 1225():127-135. PubMed ID: 32030652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
